Profile: Miraculins Inc. develops diagnostic tests for clinical needs. We develop diagnostic tests for diseases and conditions that lack highly sensitive and specific tests. Our product pipeline includes prostate cancer program, preeclampsia program, colorectal cancer program, pancreatic cancer program, gastric cancer program and breast cancer program. We also develop prostate cancer diagnostics that can accurately identify cancer positives, and correctly classify those without cancer, with a sensitivity & specificity. Our protein & peptide markers can be used to improve the information available to physicians and therefore improve the quality of treatment for the patients.